| 2024 | | The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinoma | 고영화, 이현우, 한재호, 함석진 |
| 2024 | | USP11 Modulates Mitotic Progression and Senescence by Regulating the p53-p21 Axis Through MDM2 Deubiquitination | 이재호 |
| 2024 | | Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's disease | 김현아 |
| 2024 | | Clinician-Driven Reanalysis of Exome Sequencing Data From Patients With Inherited Retinal Diseases | 정승아 |
| 2024 | | The impact of the expanded health insurance coverage policy on healthcare spending: evidence from Korea | 이문재 |
| 2024 | | A multimodal machine learning model for predicting dementia conversion in Alzheimer’s disease | 손상준 |
| 2024 | | SEP-AlgPro: An efficient allergen prediction tool utilizing traditional machine learning and deep learning techniques with protein language model features | Basith, Shaherin, 이광 |
| 2024 | | 8-Iso-prostaglandin F2α as a biomarker of type 2 low airway inflammation and remodeling in adult asthma | 박해심 |
| 2024 | | Sialyllactose preserves residual hearing after cochlear implantation | 장정훈, 정연훈 |
| 2024 | | Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study | 이광노 |
| 2024 | | Analysis of the spatial and morphological characteristics of oligodendrocytes from images of in vitro culture | 고승연, 김병곤, 최준영 |
| 2024 | | Predicted brain age (PBA), promising surrogate indicator for neurodevelopment in preterm baby: how to predict accurately? | 한미란 |
| 2024 | | Correction to: Medical expenses and its determinants in female patients with urological disorder | 이문재 |
| 2024 | | Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia | 박해심 |
| 2024 | | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis | 김태준 |
| 2024 | | An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer | 김철호, 이복순, 이윤상 |
| 2024 | | Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees | 김영롱, 김은진, 유진세, 최영화, 허중연, 현학준 |
